Cargando…

SARS-CoV-2: The viral shedding vs infectivity dilemma

Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over four million people worldwide. There are multiple reports of prolonged viral shedding in people infected with SARS-CoV-2 but the presence of viral RNA on a test does not necessarily correlate with inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Widders, Arabella, Broom, Alex, Broom, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Australasian College for Infection Prevention and Control. Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237903/
https://www.ncbi.nlm.nih.gov/pubmed/32473952
http://dx.doi.org/10.1016/j.idh.2020.05.002
Descripción
Sumario:Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over four million people worldwide. There are multiple reports of prolonged viral shedding in people infected with SARS-CoV-2 but the presence of viral RNA on a test does not necessarily correlate with infectivity. The duration of quarantine required after clinical recovery to definitively prevent transmission is therefore uncertain. In addition, asymptomatic and presymptomatic transmission may occur, and infectivity may be highest early after onset of symptoms, meaning that contact tracing, isolation of exposed individuals and social distancing are essential public health measures to prevent further spread. This review aimed to summarise the evidence around viral shedding vs infectivity of SARS-CoV-2.